David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinkedIn:
“Fantastic EGFRm session diving into the evolving post-FLAURA/FLAURA2 landscape for EGFRmut patients.
The field is moving rapidly!”
More posts about OncoBroncho2026
